The store will not work correctly when cookies are disabled.
N,N-dimethyl-2-(6-(4-methylthiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide
ID: ALA4529810
PubChem CID: 124175991
Max Phase: Preclinical
Molecular Formula: C16H17N3OS
Molecular Weight: 299.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1csc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)c1
Standard InChI: InChI=1S/C16H17N3OS/c1-11-6-15(21-10-11)12-7-14-13(17-8-12)4-5-19(14)9-16(20)18(2)3/h4-8,10H,9H2,1-3H3
Standard InChI Key: GFVHWHJSAPNZOO-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
26.7595 -16.0796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7584 -16.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4664 -17.3081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4646 -15.6708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1733 -16.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1781 -16.8947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9581 -17.1431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4355 -16.4780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9503 -15.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2151 -17.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0154 -18.0841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2725 -18.8598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5587 -17.4736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7292 -19.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0728 -19.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0504 -17.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3026 -16.9757 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.7553 -17.5826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1634 -18.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9628 -18.1213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8305 -19.0369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
19 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.40 | Molecular Weight (Monoisotopic): 299.1092 | AlogP: 3.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.06 | CX LogP: 2.52 | CX LogD: 2.52 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: -1.88 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |